Functional proteomics
and molecular pharmacology of pediatric cancers

Genomic plasticity and DNA transposases in childhood tumors

Half of the human genome originates from mobile DNA elements, or transposons, but their contributions to human disease and physiology remain largely unexplored. (more…)

Read More

Epigenetic signaling and rational therapy of acute myeloid leukemia

Extensive genome sequencing has produced a nearly complete compendium of genetic aberrations in both pediatric and adult acute myeloid leukemias. In spite of this, the molecular mechanisms of aberrant cell…

Read More

High-accuracy mass spectrometry for the discovery and drugging of cancer proteomes

Epigenetic dysregulation is becoming increasingly recognized as an important driver of human cancer, and childhood tumors in particular. The use of massively parallel RNA sequencing is beginning to reveal the…

Read More

Kentsis Research Group Overview

We are a group of physicians and scientists in the Molecular Pharmacology Program at the Sloan Kettering Institute and Department of Pediatrics at the Memorial Sloan Kettering Cancer Center. We carry out research in cancer biology and pediatric oncology, and our current work is focused on the phenomenon of cellular plasticity, as it relates both to the fundamental mechanisms of cancer pathogenesis and emerging rational therapies.

Projects

Genomic plasticity and DNA transposases in childhood tumors
Read More
Epigenetic signaling and rational therapy of acute myeloid leukemia
Read More
High-accuracy mass spectrometry for the discovery and drugging of cancer proteomes
Read More

Publications

prohibitin
Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms’ tumor
pr-2019-00085g_0006
Optimized cross-linking mass spectrometry for in situ interaction proteomics
pr-2018-00295f_0001
ProteomeGenerator: A framework for comprehensive proteomics based on de novo transcriptome assembly and high-accuracy peptide mass spectral matching

Blog

Urine proteomics to discover prognostic biomarkers and improved therapeutic targets for kidney tumors
Read More
Ultrasensitive pathway-scale functional proteomics using the Quantitative Cell Proteomics Atlas at Single Cell Proteomics 2019
Read More
Is it possible to use cross-linking mass spectrometry to identify protein-protein interactions in living cells?
Read More